Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis
- 1 December 1995
- journal article
- review article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 26 (3) , 201-208
- https://doi.org/10.1007/bf01052623
Abstract
CD44s (standard form of CD44) is a transmembrane glycoprotein whose external domain displays extracellular matrix adhesion properties by binding both hyaluronic acid (HA) and collagen. The cytoplasmic domain of CD44s interacts with the cytoskeleton by binding directly to ankyrin. It has been shown that post-translational modifications, such as phosphorylation (by protein kinase C), acylation (by acyl-transferase) and GTP-binding enhance CD44's interaction with cytoskeletal proteins. Most importantly, the interaction between CD44s and the cytoskeletal protein, ankyrin, is required for the modulation of CD44s cell surface expression and its adhesion function. Recently, a number of tumor cells and tissues have been shown to express CD44 variant (CD44v) isoforms. Using RT-PCR and DNA sequence analyses, we have found that unique CD44 splice variant isoforms are expressed in both prostate and breast cancer cell lines and carcinomas. Most importantly, intracellular ankyrin is preferentially accumulated underneath the patched/capped structures of CD44 variant isoform in both breast and prostate cancer cells attached to HA-coated plates. We propose that selective expression of CD44v isoforms unique for certain metastatic carcinomas and their interaction with the cytoskeleton may play a pivotal role in regulating tumor cell behavior during tumor development and metastasis.Keywords
This publication has 47 references indexed in Scilit:
- Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.The Journal of cell biology, 1994
- Human primary prostate tumor cell line, ALVA‐31: A new model for studying the hormonal regulation of prostate tumor cell growthThe Prostate, 1993
- Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition.The Journal of cell biology, 1992
- Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.The Journal of Experimental Medicine, 1991
- Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures.The Journal of Experimental Medicine, 1990
- CD44 — A molecule involved in leukocyte adherence and T-cell activationImmunology Today, 1989
- Homing Receptors and Vascular Addressins: Cell Adhesion Molecules that Direct Lymphocyte TrafficImmunological Reviews, 1989
- Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrinThe Journal of cell biology, 1988
- Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells.The Journal of cell biology, 1987
- Evidence that the Pgp-1 glycoprotein is expressed on thymus-homing progenitor cells of the thymusCellular Immunology, 1985